DBS Targets S$1 Trillion Wealth AUM by 2030 Amid Asia Wealth Boom 
United Airlines Beats Q2 Earnings, Raises 2026 Profit Outlook Despite Higher Fuel Costs 
Arm Stock Falls After HSBC Downgrade, Citing Limited Near-Term AI Upside 
ASML Raises 2026 Outlook as AI Chip Demand Lifts Q2 Earnings 
Paramount-Warner Bros. Discovery Merger Faces Lawsuit From 12 States 
Nvidia Partners With Fanuc and Yaskawa to Accelerate AI Robotics in Japan 
SpaceX Stock Falls Below IPO Price as Investors Weigh Losses and Lockup Expiry 
Rio Tinto Reports Strong Q2 Iron Ore Sales, Maintains 2026 Production Outlook 
Stripe, Advent Offer $53 Billion Deal to Acquire PayPal: Reuters 
DeepSeek Eyes China IPO as AI Startup Seeks $71 Billion Valuation in New Funding Round 
BHP Faces Major Port Hedland Strike as Labor Talks Stall Ahead of Production Report 
Airbus Signs Cloud Deal With Scaleway to Power Secure AI and Defense Applications 
Apple Intelligence China Approval Lifts Alibaba and Baidu Shares 
Richemont Q1 Sales Beat Forecast as Cartier Demand Drives Strong Growth 
Stripe, Advent Offer Over $53 Billion to Acquire PayPal in Major Fintech Deal 
UBS Boosts China Tech Bets, Adds Kuaishou and Meituan to Focus List 
Eli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health Pipeline 
 Shares Announced by Shareholders Foundation - EconoTimes)
SAN DIEGO, Jan. 27, 2016 -- The Shareholders Foundation, Inc. announces that a lawsuit was filed in New York on behalf of certain investors who purchased of shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) over alleged Securities Laws Violations by Anavex Life Sciences.
Investors who purchased shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) have certain options and for certain investors are short and strict deadlines running. Deadline: February 29, 2016. (NASDAQ:AVXL) investors should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.
The plaintiff claims that the defendants made certain allegedly false and/or misleading statements and/or allegedly failed to disclose that Anavex had used a paid stock promoter to artificially inflate the Company’s share price and that as a result of the foregoing, Anavex’s public statements were materially false and misleading at all relevant times.
On December 29, 2015, Anavex Life Sciences Corp. disclosed that it had received a subpoena from the U.S. Securities and Exchange Commission (“SEC”) on December 22, 2015. Anavex Life Sciences Corp. stated, in part, that "[t]he Company believes the subpoena and investigation relate to the recent unusual activity in the market for the Company's shares."
On December 30, 2015, a report was published entitled “Anavex: A Regulatory Target Damaged By Incriminating Evidence.”
Those who purchased (NASDAQ:AVXL) shares have certain options and should contact the Shareholders Foundation, Inc. by e-mail at [email protected] or call +1 (858) 779-1554.
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
CONTACT: Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
[email protected]
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
